Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
acetylon pharmaceuticals
ambys medicines
amgen
biotech
cell therapy
cholesterol
clinical trials
constellation pharmaceuticals
data
deals
gene therapy
genentech
holger willenbring
inclisiran
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
ldl
liver disease
mark timney
markus grompe
martin burke
mt sinai hospital
new york
oregon stem cell center
pcsk9
peter wijngaard
praluent
prashant vaishnava
proteon therapeutics
What
big
2
×
medicines
2
×
aces
aiming
ambys
announced
biotech
ceo
cholesterol
control
deadly
deal
debuted
diseases
drug
flexible
formed
future
inclisiran
key
launch
liver
lowering
make
meant
medco
medicine
nasdaq
new
open
passed
pricing
startup
takeda
taken
test
today
treatments
twice
unusual
Language
unset
Current search:
big
×
" boston blog main "
×
medicines
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
